Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
142
天
14
天
Indole-based derivatives as anticancer agents: recent advances in structure–activity relationships and biological mechanisms
作者
Aashik Malik; Mayank Yadav; Jai Parkash Kadian; Komal Mishra; Ramsha; Anurag Rathore; Manisha; Nishant Rathour展开收起
作者单位
1. Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, India展开收起
68
天
Design and mechanistic evaluation of chalcone–quinoline–triazole hybrids as antifungal CYP51 inhibitors
作者
Rudi Hendra; Rahmad Setiawan Rabby; Tengku Anggia Fitri; Hilwan Yuda Teruna; Neni Frimayanti展开收起
作者单位
1. Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Indonesia; 2. Centre of Biological Innovation for Regenerative and Natural Applications, Universitas Riau, Pekanbaru, Indonesia; 3. Master Degree Program, Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Indonesia; 4. Riau College of Pharmaceutical Sciences, Tampan, Pekanbaru, Indonesia展开收起
4
天
From propofol to cipepofol (Cypsedo®), a new intravenous general anesthetic approved for adults undergoing surgery
作者
Longqin Hu展开收起
作者单位
1. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA; 2. The Cancer Institute of New Jersey, New Brunswick, USA展开收起
57
天
28
天
Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights
作者
Tashi Palmo; Vishwani Jamwal; Karan Goel; Anuj Kumar; Somdutt Mujwar; Yogesh P. Bharitkar; Kuljit Singh展开收起
作者单位
1. Infectious Diseases Division, CSIR- Indian Institute of Integrative Medicine, Jammu, India; 2. Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India; 3. Chitkara College of Pharmacy, Chitkara University, Rajpura, India; 4. Natural Products & Medicinal Chemistry Division, CSIR- Indian Institute of Integrative Medicine, Jammu, India展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天